Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large drop in short interest in December. As of December 31st, there was short interest totaling 6,940 shares, a drop of 56.3% from the December 15th total of 15,881 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 15,806 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily volume of 15,806 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.2% of the shares of the stock are sold short.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in PJP. DHJJ Financial Advisors Ltd. acquired a new stake in shares of Invesco Pharmaceuticals ETF in the 2nd quarter valued at approximately $28,000. AE Wealth Management LLC increased its position in Invesco Pharmaceuticals ETF by 21.5% during the 2nd quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock worth $57,000 after purchasing an additional 127 shares in the last quarter. CIBC Bancorp USA Inc. bought a new position in Invesco Pharmaceuticals ETF in the 3rd quarter valued at approximately $203,000. Jones Financial Companies Lllp boosted its position in Invesco Pharmaceuticals ETF by 11.6% in the first quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock valued at $210,000 after buying an additional 252 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its position in Invesco Pharmaceuticals ETF by 5.7% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 2,791 shares of the company’s stock valued at $258,000 after buying an additional 150 shares in the last quarter.

Invesco Pharmaceuticals ETF Stock Performance

Shares of Invesco Pharmaceuticals ETF stock traded up $0.93 during trading on Wednesday, reaching $105.69. 16,835 shares of the company’s stock were exchanged, compared to its average volume of 154,593. Invesco Pharmaceuticals ETF has a 1-year low of $72.25 and a 1-year high of $108.40. The company has a market cap of $329.75 million, a P/E ratio of 15.59 and a beta of 0.50. The firm’s 50-day moving average price is $104.72 and its 200 day moving average price is $94.81.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.